‘Idea test lab’ to boost new businesses | RSS News Feed

‘Idea test lab’ to boost new businesses - Latest News

RSS Feed for this news: ‘Idea test lab’ to boost new businesses

Simple blood test combined with exacerbation history may help to identify when to add ICS to COPD treatment

LONDON & INGELHEIM, Germany--(BUSINESS ... agonist (LABA, salmeterol 50μg twice daily) with regard to reducing exacerbation risk. 1,3 Eosinophils, which are a type of white blood cell, are assessed as part of a routine blood test. 4 This new post-hoc ... read more

The Seven Pillars of ICO Investing

In addition to the hundreds of ICOs being launched every month, our management company Crypto Asset Management (CAM), also receives around a dozen emails per day from new ... on an "A" idea. A talented group of people are the lifeblood of any business ... read more

Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion

LABA/LAMA combinations are expected to become a new class of treatment for COPD. A global Phase III program has been initiated and will test the improvement in lung ... innovation-driven biopharmaceutical business that focuses on the discovery ... read more

Looking for another news?


Hone Your Skills at One of These Small Biz Events

This event draws Business Owners, Corporations, Government Agencies, and Sponsors from all over New ... on a idea, a co-founder, specific skill sets, or a team to help you execute, Startup Weekends are the perfect environment in which to test your idea ... read more

Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update

Investors were disappointed by the update and shares were down 23.4% (Read more: Supernus Drops SPN-810's Lower Dose Test in Phase III Trials ... Teva Divests Women’s Health Business: Teva TEVA, which recently got a new Chief Executive Officer ... read more

AstraZeneca's (AZN) CEO Pascal Soriot on Q4 2015 Results - Earnings Call Transcript

It's a new Growth Platform ... medicine has you achieved around 15% market share in the LABA/LAMA market. In the fourth quarter we also entered into an agreement to acquire Takeda's Respiratory business. This was a very good elegant deal. read more

Ultimate Guide to MLS Weekend: Breaking Down Conference Semifinal 2nd Legs

The New York Red Bulls were the only road team to win the first ... the Whitecaps and Timbers both failing to find the back of the net at Providence Park. Now the focus shifts to the business end of the conference semifinals, which begin with one of ... read more

New Large-Scale Trial Results Show Stiolto® Respimat® Prevents COPD Exacerbations Better Than Spiriva® Respimat®

The study results also show Stiolto Respimat significantly reduced COPD symptoms and improved health-related quality of life, as measured by the COPD Assessment Test ... if LABA medicines, such as olodaterol (one of the medicines in STIOLTO), increase ... read more

Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced that the results from the pioneering Salford Lung Study (SLS) have been published in the New ... increase, 95% CI 5.4 to 19.6). The COPD Assessment Test ... read more

BioTime's (BTX) CEO Adi Mohantyon Q4 2017 Results - Earnings Call Transcript

BioTime continued to grow its patent portfolio with issuance of 41 new patents, including the patent of state covering OpRegen through 2031. BioTime was awarded a grant of up to $1.56 million from the Small Business ... we’ll have a idea of what the ... read more


FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us